High Court Victory For Neurogine Capital In Action Against Emas Fintech

LABUAN, Malaysia - Sept. 28, 2022 - PRLog -- Neurogine Capital (L) Ltd, the developer and operator of Neurogine nTrade®, a money broking platform, has met with success in civil proceedings against Emas Fintech Inc. (Emas Fintech).

According to Neurogine Group Managing Director Chen Chee Peng, the suit (WA-23CY-4-01/2021) was filed last January and brought before Judicial Commissioner of the High Court of Kuala Lumpur His Lordship Dr. John Lee Kien How @ Mohd Johan Lee earlier this month. "The result is a clear victory for us and we are thankful," he said adding Neurogine Capital is represented by its legal counsel, Messrs Anton & Chen. The High Court of Malaya in Kuala Lumpur entered judgment against Emas Fintech and its CEO, Jason Kellady, for the harm inflicted on Neurogine Capital and Neurogine Group CEO Owen Chen Chee Onn.

The judgment restricts both defendants, Emas Fintech and Jason Kellady, from further publishing any defamatory materials, be it in audio or video form, against Neurogine Capital and Neurogine Group CEO Owen Chen. Neurogine Capital's lead counsel Alex Anton Netto said this decision by the High Court clearly vindicates Neurogine Capital and would hopefully repair much damage caused to its reputation brought upon by both Emas Fintech Inc and Jason Kellady respectively.

Neurogine Capital terminated its relationship with Emas Fintech December 4, 2020, and its access to Neurogine Capital's money broking platform, branded as Neurogine nTrade®, following discoveries of various Emas Fintech abuses and misrepresentations. Following the termination, Kellady publicised videos on social platforms where he blamed Emas Fintech's losses due to alleged security breaches suffered by Neurogine nTrade®. Emas Fintech ceased operations, refused to refund its customers and its management has gone into hiding. "Kellady's claims that our platform, Neurogine nTrade®, as having been hacked, is entirely false, spurious and meant to misled," said Chen.

Last June, Neurogine Group CEO Chen Chee Onn was exonerated after having found to have nil involvement with regard to the Emas Fintech Inc investment fraud case (Case 14058/2020) following receipt of Ref: (PR) 168/17, dated June 11, 2021, from Commercial Crime Investigation Division (CCID), Brickfields District Police Headquarters, Kuala Lumpur. In the same document, CCID also informed it has submitted its investigation report to the Deputy Public Prosecutor, which has reviewed and then closed the investigation. Two individuals found guilty have been brought before Court and charged under Section 420 of the Penal Code.

Neurogine Capital is part of Neurogine Group and licensed by Labuan Financial Services Authority, to provide Labuan money broking services. "Neurogine nTrade® has sufficiently matured and processed more than USD27.7 million worth of money brokering transactions in June 2022 from just USD3.7 million in January 2022. This growth reflects confidence in our platform," said Chen.

http://www.neurogine.com